We are live on ! Find out more
LEGN icon

Legend Biotech
LEGN

71 hedge funds and large institutions have $767M invested in Legend Biotech in 2021 Q1 according to their latest regulatory filings, with 22 funds opening new positions, 20 increasing their positions, 13 reducing their positions, and 12 closing their positions.

New
Increased
Maintained
Reduced
Closed

83% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 12

54% more repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 13

16% more funds holding

Funds holding: 61 → 71 (+10)

6% more capital invested

Capital invested by funds: $723M → $767M (+$43.8M)

0.36% more ownership

Funds ownership: 9.65% → 10.01% (+0.36%)

25% less funds holding in top 10

Funds holding in top 10: 4 → 3 (-1)

69% less call options, than puts

Call options by funds: $263K | Put options by funds: $836K

Holders
71
Holders Change
+10
Holders Change %
+16.39%
% of All Funds
1.25%
Holding in Top 10
3
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-25%
% of All Funds
0.05%
New
22
Increased
20
Reduced
13
Closed
12
Calls
$263K
Puts
$836K
Net Calls
-$573K
Net Calls Change
-$573K

Top Buyers

1
Point72 Asset Management
Point72 Asset Management
Connecticut
+$44.7M
2
CCM
Consonance Capital Management
New York
+$24.5M
3
AllianceBernstein
AllianceBernstein
Tennessee
+$24.3M
4
Artisan Partners
Artisan Partners
Wisconsin
+$23M
5
MWNA
Marshall Wace North America
New York
+$11.2M

Top Sellers

1
RCM
RA Capital Management
Massachusetts
-$67.8M
2
Adage Capital Partners
Adage Capital Partners
Massachusetts
-$19.1M
3
Hudson Bay Capital Management
Hudson Bay Capital Management
Connecticut
-$15.5M
4
T. Rowe Price Associates
T. Rowe Price Associates
Maryland
-$12.4M
5
WP
Woodline Partners
California
-$12.1M
Name Holding Trade Value Shares
Change 		Change in
Stake
Bank of America
51
Bank of America
North Carolina
$295K +$275K +10,099 +18,362%
VEA
52
Virtus ETF Advisers
New York
$291K +$4.96K +182 +2%
WMSA
53
Weiss Multi-Strategy Advisers
New York
$278K +$261K +9,582 New
Goldman Sachs
54
Goldman Sachs
New York
$243K -$167K -6,121 -42%
Susquehanna International Group
55
Susquehanna International Group
Pennsylvania
$217K +$204K +7,486 New
DekaBank Deutsche Girozentrale
56
DekaBank Deutsche Girozentrale
Germany
$172K – – –
Deutsche Bank
57
Deutsche Bank
Germany
$151K – – –
Legal & General Group
58
Legal & General Group
United Kingdom
$96K – – –
UBS Group
59
UBS Group
Switzerland
$54K -$3.08K -113 -6%
TRCT
60
Tower Research Capital (TRC)
New York
$41K -$144K -5,292 -79%
PCM
61
Penserra Capital Management
California
$15K +$1.36K +50 +10%
Citigroup
62
Citigroup
New York
$13K -$4.99K -183 -29%
Bank of Montreal
63
Bank of Montreal
Ontario, Canada
$12K +$11.2K +410 New
KFA
64
Krane Funds Advisors
New York
$11K – – –
QCG
65
Quadrant Capital Group
Ohio
$8K +$2.18K +80 +40%
S
66
SignatureFD
Georgia
$4K – – –
GAM
67
Gemmer Asset Management
California
$3K – – –
Macquarie Group
68
Macquarie Group
Australia
$2K – – –
Daiwa Securities Group
69
Daiwa Securities Group
Japan
$1K – – –
RCM
70
RA Capital Management
Massachusetts
– -$67.8M -2,408,292 Closed
WP
71
Woodline Partners
California
– -$12.1M -431,418 Closed
Jennison Associates
72
Jennison Associates
New York
– -$9.05M -321,388 Closed
JCAM
73
Jericho Capital Asset Management
New York
– -$5.72M -203,000 Closed
Nomura Holdings
74
Nomura Holdings
Japan
– -$3.85M -130,632 Closed
DVF
75
Discovery Value Fund
Singapore
– -$1.77M -62,783 Closed
1 2
3
4

LEGN Hedge Fund Activity: Q1 2021 in Review

71 of the 5,695 institutional investors tracked by Wall St. Rank reported a position in Legend Biotech (LEGN) for Q1 2021, worth a combined $767M — up 6.1% from $723M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new LEGN positions and 12 closed out — a net gain of 10 holders — while 20 added to existing stakes and 13 trimmed.

The largest buyer was Point72 Asset Management, opening a new position worth an estimated $44.7M. The largest seller was RA Capital Management, exiting entirely with an estimated $67.8M sold.

  • 71 institutional investors held Legend Biotech (LEGN) as of Q1 2021, up from 61 in Q4 2020.
  • Funds reported $767M of Legend Biotech stock for Q1 2021, up 6.1% quarter-over-quarter.
  • 22 funds opened new Legend Biotech positions in Q1 2021 and 12 closed out, a net change of +10 holders.
  • The largest Legend Biotech buyer in Q1 2021 was Point72 Asset Management, an estimated $44.7M added.
  • The largest Legend Biotech seller in Q1 2021 was RA Capital Management, an estimated $67.8M sold.

Based on aggregated 13F filings for Q1 2021.